Olmesartan for the prevention or delay of diabetic nephropathy: some considerations

Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):678-9; author reply 679-80. doi: 10.1016/j.recesp.2012.03.006. Epub 2012 May 17.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Albuminuria / drug therapy*
  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Diabetes Mellitus, Type 2 / mortality*
  • Diabetic Cardiomyopathies / drug therapy*
  • Female
  • Humans
  • Imidazoles / adverse effects*
  • Imidazoles / therapeutic use*
  • Male
  • Tetrazoles / adverse effects*
  • Tetrazoles / therapeutic use*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Imidazoles
  • Tetrazoles